UK-based pharmaceutical giant AstraZeneca plans to build its largest drug manufacturing facility in Virginia, creating ...

While Maryland remains a critical R&D hub for AstraZeneca, Virginia’s selection as the manufacturing cornerstone also highlights the state’s rising prominence in advanced pharmaceutical production, ...

RICHMOND, Va. (WDBJ) - Astrazeneca is deciding where in Virginia it will establish its newest multi-billion dollar ...

Gov. Glenn Youngkin speaks with Janet Roach about pharmaceutical company AstraZeneca building a facility in Virginia.

RICHMOND, Va. — Virginia Gov. Glenn Youngkin is speaking out about the recent announcement that the state is poised to become ...

AstraZeneca's strategic $50B investment promises to revolutionize U.S. medicine production with advanced manufacturing and ...

The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, alongside additional facilities in California, Indiana, Maryland, ...

AstraZeneca (Cambridge, U.K.) announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines ...

Meanwhile, President Trump continues to push reciprocal levies and reshoring efforts, while pharma prepares for escalating costs.

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

As part of a growing trend of pharmaceutical giants reshoring their operations, AstraZeneca (AZN) announced Monday that it will invest $50 billion in U.S. manufacturing by 2030. This is the company’s ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...